Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
44
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
52%
ALSO IN IBBQ
IBBQ
213
HOLDINGS
21%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus IBBQ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 1.9% | 7.2% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 7.7% | 1.8% |
|
AMGEN INC | 1.7% | 7.5% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.8% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.7% | 1.4% | 1.4% |
WDNA Overweight Relative to IBBQ
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.0% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.3% |
|
VERACYTE INC | 1.8% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
BLUEPRINT MEDICINES CORP. | 1.7% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
WDNA Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -5.9% |
|
AMGEN INC | -5.8% |
|
GILEAD SCIENCES INC | -5.3% |
|
REGENERON PHARMACEUTICALS | -5.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.0% |
|
ALNYLAM PHARMACEUTICALS INC | -2.1% |
|
SUMMIT THERAPEUTICS INC | -2.0% |
|
INSMED INC | -1.9% |
|
ROYALTY PHARMA PLC CLASS A | -1.6% |
 |
SANOFI-AVENTIS-ADR | -1.4% |